Stocks
Agios Pharmaceuticals (AGIO) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -3.15 | 1.83 | 1.83 | -2.45 | -1.92 | -2.78 | ||
| Changes by years, y/y, % | -61% | -158% | 0% | -234% | -22% | -25.0% | |||
Agios Pharmaceuticals. EV/EBITDA
Agios Pharmaceuticals. EV/EBITDA, changes, %
Agios Pharmaceuticals (AGIO) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -1.94 | -2.35 | -3.23 | -1.82 | -3.08 | -2.78 | |
| Changes by years, y/y, % | -237% | -286% | -18% | -27% | +59% | |||
| Changes by quarters, q/q, % | -22% | +21% | +37% | -44% | +69% | |||
